Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lung Neoplasms 6Breast Neoplasms 6Meningeal Carcinomatosis 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Lymphoma, Large B-Cell, Diffuse 4Leukemia, Biphenotypic, Acute 4Myelodysplastic Syndromes 3Glioblastoma 3Astrocytoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Glioma 2Brain Neoplasms 2Uveal Melanoma 1Rhabdomyosarcoma 1Oligodendroglioma 1Nevus 1Neoplastic Cells, Circulating 1Neoplasm Recurrence, Local 1Multiple Myeloma 1Meningioma 1Meningeal Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1

Interventions

pembrolizumab 1TP protocol 1Spinal Puncture 1Radiotherapy 1Lomustine 1Cetuximab 1Blood Specimen Collection 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Recurrence, Local × Spinal Puncture × 1 year × Clear all
NCT07398170 2026-02-09

BIOLIMEN-1

University Hospital, Montpellier

Phase NA Not yet recruiting
15 enrolled
CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡